ExodusPoint Capital Management’s AngioDynamics ANGO Stock Holding History

ExodusPoint Capital Management’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$407K	Buy	+31,274	New	+$356K	﹤0.01%	1288
2026 Q1	–	Sell	-47,402	Closed	-$609K	–	1532
2025 Q4	$609K	Buy	47,402 +31,845	+205%	+$393K	﹤0.01%	1144
2025 Q3	$174K	Buy	+15,557	New	+$150K	﹤0.01%	1401
2024 Q4	–	Sell	-63,960	Closed	-$498K	–	1487
2024 Q3	$498K	Sell	63,960 -953,874	-94%	-$6.89M	﹤0.01%	1187
2024 Q2	$6.16M	Buy	1,017,834 +828,174	+437%	+$5.11M	0.04%	350
2024 Q1	$1.11M	Sell	189,660 -439,943	-70%	-$2.61M	0.01%	910
2023 Q4	$4.94M	Sell	629,603 -187,789	-23%	-$1.3M	0.03%	346
2023 Q3	$5.97M	Buy	817,392 +644,316	+372%	+$5.36M	0.06%	332
2023 Q2	$1.8M	Buy	+173,076	New	+$1.67M	0.01%	852
2023 Q1	–	Sell	-19,604	Closed	-$270K	–	1729
2022 Q4	$270K	Buy	+19,604	New	+$273K	﹤0.01%	1385
2021 Q4	–	Sell	-16,626	Closed	-$431K	–	2137
2021 Q3	$431K	Buy	+16,626	New	+$445K	0.01%	1474
2021 Q1	–	Sell	-25,924	Closed	-$397K	–	2091
2020 Q4	$397K	Buy	+25,924	New	+$329K	﹤0.01%	1384

Other funds holding ANGO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Broadfin Holdings Melville, New York $23.7M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

WCM

Weber Capital Management San Francisco, California $118M AUM

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ExodusPoint Capital Management's ANGO Position: Q2 2026 in Review

ExodusPoint Capital Management opened a new position in AngioDynamics (ANGO) in Q2 2026: 31,274 shares worth $407K. The stake represents ﹤0.01% of the portfolio and ranks #1288 among its holdings. This is a return to the name: ExodusPoint Capital Management previously reported a position in ANGO as recently as Q4 2025.

ExodusPoint Capital Management first reported a position in ANGO in Q4 2020 and has held it in 12 quarters since. The position peaked at $6.16M in Q2 2024. 162 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

ExodusPoint Capital Management held 31,274 shares of AngioDynamics worth $407K as of Q2 2026.
AngioDynamics was a new ExodusPoint Capital Management position in Q2 2026.
AngioDynamics made up ﹤0.01% of ExodusPoint Capital Management's portfolio in Q2 2026, its #1288 holding.
ExodusPoint Capital Management first reported a position in AngioDynamics in Q4 2020 and has held it in 12 quarters since.
ExodusPoint Capital Management's AngioDynamics position peaked at $6.16M in Q2 2024.
162 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.